PU 02 structure
|
Common Name | PU 02 | ||
---|---|---|---|---|
CAS Number | 313984-77-9 | Molecular Weight | 292.35800 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C16H12N4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PU 02PU02, a derivative of 6-MP (HY-13677), is a negative allosteric modulator (NAM) of 5-HT3 receptor, with IC50 values of 0.36 and 0.73 μM in HEK293 cells transfected with human 5-HT3A and 5-HT3AB receptors respectively[1][2]. |
Name | 6-[(1-Naphthylmethyl)sulfanyl]-7H-purine |
---|---|
Synonym | More Synonyms |
Description | PU02, a derivative of 6-MP (HY-13677), is a negative allosteric modulator (NAM) of 5-HT3 receptor, with IC50 values of 0.36 and 0.73 μM in HEK293 cells transfected with human 5-HT3A and 5-HT3AB receptors respectively[1][2]. |
---|---|
Related Catalog | |
Target |
5-HT3A Receptor:0.36 μM (IC50) 5-HT 3 AB:0.73 μM (IC50) |
In Vitro | PU02 (NMMP) (0-200 μM) leads to a steady decrease in cell viability of HepG2 cells (IC50=48.585 μM). PU02 (NMMP) shows less toxicity on L02 cells than did 6-MP after 48 h of treatment[2]. PU02 (NMMP) at 6.25 or 25 μM exhibits inhibitory effects on the viability of the tested cell lines, including SMMC-7721, MDA-MB-231, RKO and HCT-8 cells[2]. PU02 (NMMP) induces cell cycle arrest at the G2/M phase. PU02 (NMMP) downregulats the expression of cyclin B1/D1 and CDK4 in a time-dependent manner in HepG2 cells,but the expression of cyclin E is not affected[2]. PU02 (NMMP)-treated cells exhibits a significant increase in caspase-3 cleavage, suggesting enhanced apoptotic activity[2]. Apoptosis Analysis[2] Cell Line: HepG2 cells. Concentration: 6.26, 12.5, 25, 50 μM. Incubation Time: 6, 12, 24, 36 h. Result: Induced mitochondria-dependent apoptosis. |
References |
Molecular Formula | C16H12N4S |
---|---|
Molecular Weight | 292.35800 |
Exact Mass | 292.07800 |
PSA | 79.76000 |
LogP | 3.79840 |
Hazard Codes | Xi |
---|
MFCD23381174 |